article thumbnail

Do patients care about accelerated approval drugs?

World of DTC Marketing

The program was codified into law under the Food and Drug Safety and Innovation Act (FDASIA) in 2012. Accelerated Approval was developed in 1992 in response to the HIV/AIDS crisis and has led to expedited drug and biologic approvals in several disease areas across the FDA.

Patients 200
article thumbnail

Lessons from the Top 100: Thales [Podcast]

Clarivate

Every year since 2012, Clarivate has identified the Top 100 Global Innovators. These companies and institutions lead the global innovation landscape, contributing new ideas, solving some of the world’s most complex challenges and creating new value. Listen to the podcast.

Leads 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Five Years of Forbes | Legacy MEDSearch Ranks on the Forbes Best Executive Recruitment Firms for a Fifth Consecutive Year

Legacy MEDSearch

Leadership includes Joy Celebre (recruiting since 1996, joined in 2008), Carolyn Jones (recruiting since 1995, joined in 2011), Arshad Alam (recruiting since 1995, joined 2017), John White (Talent Sourcing Manager, joined 2012), and Partner Chris Miclot, (joined 2012). “In

article thumbnail

Healthcare Systems Today And The Role Of Social Media Within It With Dr. Alejandro Badia

Evolve Your Success

Dr. Badia’s journey from his immigrant roots to becoming a leading medical practitioner in Miami is truly inspiring. Learn how a childhood experience with his grandmother’s rheumatoid arthritis ignited his passion for hand surgery, leading to his extensive training at N.Y.U. and a transformative fellowship in Pittsburgh.

Media 130
article thumbnail

Shorter timelines, evolving strategies: Four key trends in regulatory approvals of new medicines

Clarivate

The following blog post summarizes key findings from the latest CIRS R&D Briefing, New drug approvals in six major authorities 2012-2021. The resulting analyses, published annually since 2012, give unique insights into regulatory processes and practices, identify where improvements can be made and inform company and agency strategies.

article thumbnail

After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome

pharmaphorum

Two weeks after reporting disappointing results for its lead coeliac disease therapy, 9 Meters Biopharma will draw some comfort from a mid-stage trial of its candidate for short bowel syndrome (SBS), although its share price remains under pressure. Some children are born with an abnormally short small intestine.

Leads 98
article thumbnail

CGT Catapult to bolster new UK life sciences campus

European Pharmaceutical Review

Matthew Durdy, Chief Executive of the CGT Catapult commented: “We are delighted to be involved in the continued development of the leading life sciences cluster in Stevenage. Since its opening in 2012, occupier companies have secured £2.9bn in finance, making the cluster one of the most attractive for investment in biotechnology in the UK.